Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-000232
Filing Date
2023-01-05
Accepted
2023-01-05 16:14:06
Documents
15
Period of Report
2023-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A rkda-20230103.htm   iXBRL 8-K/A 61600
2 EX-10.1 rkda-ex10_1.htm EX-10.1 243828
3 GRAPHIC img5370606_0.jpg GRAPHIC 68051
4 GRAPHIC img5370606_1.jpg GRAPHIC 68051
  Complete submission text file 0000950170-23-000232.txt   642090

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20230103.xsd EX-101.SCH 2463
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20230103_pre.xml EX-101.PRE 10214
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20230103_lab.xml EX-101.LAB 13878
9 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20230103_htm.xml XML 5329
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37383 | Film No.: 23511445
SIC: 0100 Agricultural Production-Crops